{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:48:11Z","timestamp":1761540491856},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.atherosclerosis.2003.10.005","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T11:00:10Z","timestamp":1072868410000},"page":"281-286","source":"Crossref","is-referenced-by-count":19,"title":["Third generation oral contraceptive use and cardiovascular risk factors"],"prefix":"10.1016","volume":"172","author":[{"given":"Angela","family":"D\u00f6ring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannelore","family":"L\u00f6wel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB1","doi-asserted-by":"crossref","unstructured":"Jordan WM. Pulmonary embolism. Lancet 1961;ii:1146\u20137.","DOI":"10.1016\/S0140-6736(61)91061-3"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analyses","volume":"323","author":"Kemmeren","year":"2001","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB3","doi-asserted-by":"crossref","unstructured":"WHO Collaborative study of cardiovascular disease and steroid hormone contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1997;349:1202\u20139.","DOI":"10.1016\/S0140-6736(97)02358-1"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case-control study","volume":"318","author":"Dunn","year":"1999","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","article-title":"Hormone replacement therapy and increased plasma concentration of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB8","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.CIR.0000028463.74880.EA","article-title":"Effect of transdermal estradiol and oral conjugated estrogen on C-reractive protein in retinoid-placebo trial in healthy women","volume":"106","author":"Decensi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB9","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/01.CIR.0000074208.02226.5E","article-title":"Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response","volume":"107","author":"Silvestri","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB10","unstructured":"World Health Organisation Principal Investigators (prepared by H. Tunstall-Pedoe). The World Health Organization MONICA Project: a major international collaboration. J Clin Epidemiol 1988;34:105\u201314."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB11","first-page":"318","article-title":"Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in southern Germany. Results from the 1984\u20131985, 1989\u20131990, and 1994\u20131995 Surveys","volume":"1","author":"Hense","year":"1998","journal-title":"CVD Prev."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB12","unstructured":"Rote Liste. Verzeichnis von Fertigarzneimitteln der Mitglieder des Bundesverbandes der Pharmazeutischen Industrie e.V. Frankfurt 1994."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00001721-200306000-00015","article-title":"Measurement of plasma viscosity in stored frozen samples: a general population study","volume":"14","author":"Woodward","year":"2003","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/clinchem\/46.7.934","article-title":"Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population","volume":"46","author":"Hutchinson","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","article-title":"Safety evaluation of modern oral contraceptives","volume":"57","author":"Crook","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"128","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0010-7824(98)00020-1","article-title":"Blood coagulation and oral contraceptives. A critical review","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1054\/fipr.1999.0037","article-title":"Oral contraceptive use is associated with a systemic acute phase response","volume":"13","author":"Fr\u00f6hlich","year":"1999","journal-title":"Fibrinolysis Proteolysis"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0950-3536(05)80100-3","article-title":"Rheological influences on thrombosis","volume":"7","author":"Lowe","year":"1994","journal-title":"Bailli\u00e8re\u2019s Clin. Haematol."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/0003-4819-128-6-199803150-00008","article-title":"Epidemiology of oral contraceptives and cardiovascular disease","volume":"128","author":"Chasan-Taber","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0010-7824(98)00017-1","article-title":"Metabolic interrelationships, cardiovascular disease, and sex steroids","volume":"57","author":"Fotherby","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5122(96)00994-2","article-title":"Effects of progestagens on haemostasis","volume":"24","author":"Kuhl","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2003.10.005_BIB27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1055\/s-0037-1614338","article-title":"Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives","volume":"82","author":"Scarabin","year":"1999","journal-title":"Thromb. Haemost."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915003004763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915003004763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T14:41:29Z","timestamp":1585406489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915003004763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0021915003004763"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2003.10.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}